Founded in Sweden, with its long tradition of industrial entrepreneurship, our ambition is to create a pan-European generics pharmaceuticals company. At Bluefish Pharmaceuticals, we strive to make quality medicines accessible to more people.
Our presence in India and close collaboration with Indian development and manufacturing partners are an integral part in our effort to deliver quality products at affordable prices.
We create value by developing, manufacturing and market generic pharmaceuticals, and we take pride in doing this in an innovative, responsible and cost-efficient way.
We are rapidly building a product portfolio consisting of a broad range of high quality generics for all major therapeutic areas, including cardiovascular, central nervous system, gastrointestinal endocrinology, oncology and antibiotics.
Bluefish products all originate from a generic substance, where efficacy and safety are well documented. Through our many collaboration partners, we have access to a vast range of technology platforms, which enable us to develop and enhance the intellectual property around our product portfolio.
Focusing on the product’s medical value to patients, we are constantly evaluating novel technologies and delivery systems to enhance product quality and patient compliance, including modified release systems and sublingual technologies, conversion to oro-dispersible formulations, formulations for dry powder injections, and fixed dose combinations.
Our strategy, to develop products based on well-known substances with an improved value to patients where applicable, result in a product portfolio with a significant market potential. We achieve this at a relatively short time of development, low risk, and limited investment.
"To be for pharmaceuticals what IKEA is for furniture."
Focusing on innovation and simplicity in both thought and action, assuming responsibility in each market, being cost-efficient at each step and everyday, we will create a strong and living brand that offer quality medicine affordable for the masses.